Advances in plant molecular farming

Biotechnology Advances

Volumn 29, Issue 2, 2011, Pages 210-222

  Obembe, Olawole O ^a   Popoola, Jacob O ^a   Leelavathi, Sadhu ^b   Reddy, Siva V ^b  

^a Centre for Economic Policy and Development Research   (Nigeria)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Biosafety; Clinical development; Commercialization; Plant derived proteins; Regulation

Indexed keywords

BIOSAFETY; CLINICAL DEVELOPMENT; COMMERCIALIZATION; PLANT-DERIVED PROTEINS; REGULATION;

DRUG PRODUCTS; HEALTH RISKS; INDUSTRIAL PLANTS; MAMMALS; PRODUCTION ENGINEERING; PUBLIC RISKS; RISK PERCEPTION;

PROTEINS;

BIOLOGICAL PRODUCT; RECOMBINANT PROTEIN; VEGETABLE PROTEIN;

ADVANCED TECHNOLOGY; BIOENGINEERING; BIOSAFETY; COMMERCIALIZATION; COST-BENEFIT ANALYSIS; ENVIRONMENTAL RISK; GENE EXPRESSION; MAMMAL; MICROBIAL ACTIVITY; PERCEPTION; PHARMACEUTICAL INDUSTRY; PROTEIN; RECOMBINATION; REGULATORY APPROACH; YEAST;

BIOSYNTHESIS; BIOTECHNOLOGY; CHEMISTRY; HORIZONTAL GENE TRANSFER; METABOLISM; METHODOLOGY; MOLECULAR FARMING; PHARMACEUTICS; REVIEW; TRANSGENIC PLANT;

BIOLOGICAL PRODUCTS; BIOTECHNOLOGY; GENE TRANSFER, HORIZONTAL; MOLECULAR FARMING; PLANT PROTEINS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; TECHNOLOGY, PHARMACEUTICAL;

MAMMALIA;

EID: 79251597203     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2010.11.004     Document Type: Review

References (213)

1. Ananiev E.V., Wu C., Chamberlin M.A., Svitashev S., Schwartz C., Gordon-Kamm W., et al. Artificial chromosome formation in maize (Zea mays L.). Chromosoma 2009, 118:157-177.
2. Andow D., Daniell H., Gepts P., Lamkey K., Nafziger E., Strayer D. A growing concern. Protecting the food supply in an era of pharmaceutical and industrial crops. Union of Concerned Scientists 2004, Dec. Available from:, accessed 28/8/09. http://www.biosafety-info.net/file_dir/3079248859c6963300.pdf, D. Andow (Ed.).
3. Arlen P.A., Falconer R., Cherukumilli S., Cole A., Cole A.M., Oishi K.K., et al. Field production and functional evaluation of chloroplast derived interferon-α2b. Plant Biotechnol J 2007, 5:511-525.
4. Aviezer D., Brill-Almon E., Shaaltiel Y., Hashmueli S., Bartfeld D., Mizrachi S., et al. A plant-derived recombinant human glucocerebrosidase enzyme-a preclinical and phase I investigation. PLoS ONE 2009, 4:e4792.
5. Badri M.A., Rivard D., Coenen K., Michaud D. Unintended molecular interactions in transgenic plants expressing clinically useful proteins: the case of bovine aprotinin traveling the potato leaf cell secretory pathway. Proteomics 2009, 9:746-756.
6. Bai J.Y., Zeng L., Hu Y.L., Li Y.F., Lin Z.P., Shang S.C., et al. Expression and characteristic of synthetic human epidermal growth factor (hEGF) in transgenic tobacco plants. Biotechnol Lett 2007, 29:2007-2012.
7. Barta A., Sommengruber K., Thompson D., Hartmuth K., Matzke M.A., Matzke A.J.M. The expression of a napoline synthase human growth hormone chimeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol 1986, 6:347-357.
8. Basaran P., Rodríguez-Cerezo E. Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol 2008, 28:153-172.
9. Benchabane M., Goulet C., Rivard D., Faye L., Gomord V., Michaud D. Preventing unintended proteolysis in plant protein biofactories. Plant Biotechnol J 2008, 6:633-648.
10. Bevan M.W., Flavell R.B., Chilton M.D. A chimaeric antibiotic resistance gene as a selectable marker for plant cell transformation. Nature 1983, 304:184-187.
11. Biemelt S., Sonnewald U. Molecular farming in plants. Nature encyclopedia of life sciences 2005, Nature Publishing Group, London. http://www.els.net/, 10.1038/npg.els.0003365.
12. Biemelt S., Sonnewald U., Galmbacher P., Willmitzer L., Müller M. Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol 2003, 77:9211-9220.
13. Bock R. Plastid biotechnology: prospects for herbicide and insect resistance, metabolic engineering, and molecular farming. Curr Opin Biotechnol 2007, 18:100-106.
14. Boothe J., Nykiforuk C., Shen Y., Zaplachinski S., Szarka S., Kuhlman P., et al. Seed-based expression systems for plant molecular farming. Plant Biotechnol J 2010, 8:588-606.
15. Bosch D., Schots A. Plant glycans: friend or foe in vaccine development?. Expert Rev Vaccin 2010, 9:835-842.
16. Breyer D., Goossens M., Herman P., Sneyers M. Biosafety considerations associated with molecular farming in genetically modified plants. J Med Plants Res 2009, 3:825-838.
17. Buonaguro F.M., Butler-Ransohoff J.-E. PharmaPlant: the new frontier in vaccines. Expert Rev Vaccin 2010, 9:805-807.
18. Cardi T., Lenzi P., Maliga P. Chloroplasts as expression platform for plant-produced vaccines. Expert Rev Vaccin 2010, 9:893-911.
19. Casadevall A. Antibody-based therapies as anti-infective agents. Expert Opin Emerg Drugs 1998, 7:307-321.
20. Castilho A., Strasser R., Stadlmann J., Grass J., Jez J., Gattinger P. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010, 285:15923-15930.
21. Chase C.D. Genetically engineered cytoplasmic male sterility. Trends Plant Sci 2006, 11:7-9.
22. Chatterjee A., Das N.C., Raha S., Babbit R., Huang Q., Zeitlin D., et al. Production of xylanase in transgenic tobacco for industrial use in bioenergy and biofuel applications. In Vitro Cell Dev Biol Plant 2010, 46:198-209.
23. Chebolu S., Daniell H. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol J 2007, 5:230-239.
24. Chen M., Liu M., Wang Z., Song J., Qi Q., Wang P.G. Modification of plant N-glycans processing: the future of producing therapeutic proteins in transgenic plants. Med Res Rev 2005, 25:343-360.
25. Chikwamba R., McMurray J., Shou H., Frame B., Pegg S.E., Scott P., et al. Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) in maize. Mol Breed 2002, 10:253-265.
26. Commandeur U., Twyman R.M., Fischer R. The biosafety of molecular farming in plants. AgBiotechNet 2003, 5:ABN110.
27. Conley A.J., Joensuu J.J., Jevnikar A.M., Menassa R., Brandle J.E. Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants. Biotechnol Bioeng 2009, 103:562-573.
28. Conrad U. Polymers from plants to develop biodegradable plastics. Trends Plant Sci 2005, 10:511-512.
29. Conrad U., Fiedler U. Expression of engineered antibodies in plant cells. Plant Mol Biol 1994, 26:1023-1030.
30. Conrad U., Fiedler U. Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol 1998, 38:101-109.
31. Corrado G., Karali M. Inducible gene expression systems and plant biotechnology. Biotechnol Adv 2009, 27:733-743.
32. Cox K.M., Sterling J.D., Regan J.T., Gasdaska J.R., Frantz K.K., Peele C.G., et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 2006, 24:1591-1597.
33. D'Aoust M.-A., Couture M.M.-J., Charland N., Trépanier S., Landry N., Ors F., et al. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 2010, 8:607-609.
34. Daniell H., Lee S.B., Panchal T., Wiebe P.O. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 2001, 311:1001-1009.
35. Daniell H., Streatfield S.J., Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals, and edible vaccines in plants. Trends Plant Sci 2001, 6:219-226.
36. De Jaeger G., Scheffer S., Jacobs A., Zambre M., Zobell O., Goossens A., et al. Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat Biotechnol 2002, 20:1265-1268.
37. De Muynck B., Navarre C., Nizet Y., Stadlmann J., Boutry M. Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Res 2009, 18:467-482.
38. De Muynck B., Navarre C., Boutry M. Production of antibodies in plants: status after twenty years. Plant Biotechnol J 2010, 8:529-563.
39. De Paepe A., De Buck S., Hoorelbeke K., Nolf J., Peck I., Depicker A high frequency of single copy T-DNA transformants by floral dip in CRE-expressing Arabidopsis plants. Plant J 2009, 59:517-527.
40. Decker E.L., Reski R. The moss bioreactor. Curr Opin Plant Biol 2004, 7:166-170.
41. Decker E.L., Reski R. Current achievements in the production of complex biopharmaceuticals with moss bioreactors. Bioprocess Biosyst Eng 2008, 31:3-9.
42. Drake P.M., Chargelegue D.M., Vine N.D., van Dolleweerd C.J., Obregon P., Ma J.K.C. Rhizosecretion of a monoclonal antibody protein complex from transgenic tobacco roots. Plant Mol Biol 2003, 52:233-241.
43. Drake P.M., Barbi T., Sexton A., McGowan E., Stadlmann J., Navarre C., et al. Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. FASEB J 2009, 23:3581-3589.
44. During K., Hippe S., Kreutzaler F., Schell J. Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tobacum. Plant Mol Biol 1990, 15:281-293.
45. Elias-Lopez A.L., Marquina B., Gutierrez-Ortega A., Aguilar D., Gomez-Lim M., Hernández-Pando R. Clinical and experimental immunology transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis. Clin Exp Immunol 2008, 154:123-133.
46. European Parliament Regulation (EC) No 1829/2003 of the European Parliament and of the council of 22 September 2003 on genetically modified food and feed. Off J Eur Union 2003, 268:1-23. Available from:, accessed 20/8/09. http://eurlex.europa.eu/LexUriServ/site/en/oj/2003/l_268/l_26820031018en00010023.pdf.
47. Faye L., Gomord V. Success stories in molecular farming-a brief overview. Plant Biotechnol J 2010, 8:525-528.
48. Fischer R., Emans N.J., Twyman R.M., Schillberg S. Molecular farming in plants: technology platforms. Encyclopedia of plant and crop science 2004, 753-756. Marcel Dekker, New York. R.B. Goodman (Ed.).
49. Floss D.M., Sack M., Arcalis E., Stadlmann J., Quendler H., Rademacher T., et al. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J 2009, 7:899-913.
50. Franconi R., Massa S., Illiano E., Mullar A., Cirilli A., Accardi L., et al. Exploiting the plant secretory pathway to improve the anticancer activity of a plant-derived HPV16 E7 vaccine. Int J Immunopathol Pharmacol 2006, 19:187-197.
51. Franconi R., Demurtas O.C., Massa S. Plant-derived vaccines and other therapeutics produced in contained systems. Expert Rev Vaccin 2010, 9:877-892.
52. Franklin S.E., Mayfield S.P. Prospects for molecular farming in the green alga Chlamydomonas. Curr Opin Plant Biol 2004, 7:159-165.
53. Fujiwara Y., Aiki Y., Yang L., Takaiwa F., Kosaka, Tsuji N.M., et al. Extraction and purification of human interleukin-10 from transgenic rice seeds. Protein Expr Purif 2010, 72:125-130.
54. Fulton L., Howes T., Hardy J. Biofuels for transport-an international perspective 2004, Available from:, International Energy Agency, Paris, France, accessed 18/9/09. http://www.iea.org/textbase/nppdf/free/2004/biofuels2004.pdf.
55. Gidoni D., Srivastava V., Carmi N. Site-specific excisional recombination strategies for elimination of undesirable transgenes from crop plants. InVitro Cell Dev Biol Plant 2008, 44:457-467.
56. Gilbert N. Europe prepares for drugs from GM plants. Nature 2009, 460:791.
57. Gils M., Marillonnet S., Werner S., Grätzner R., Giritch A., Engler C., et al. A novel hybrid seed system for plants. Plant Biotechnol J 2008, 6:226-235.
58. Giorgi C., Franconi R., Rybicki E.P. Human papillomavirus vaccines in plant. Expert Rev Vaccin 2010, 9:913-924.
59. Giritch A., Marillonnet S., Engler C., van Eldik G., Botterman J., Klimyuk V., et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci USA 2006, 103:14701-14706.
60. Gleba Y., Klimyuk V., Marillonnet S. Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine 2005, 23:2042-2048.
61. Gomord V., Fitchette A.-C., Menu-Bouaouiche L., Saint-Jore-Dupas C., Plasson C., Michaud D., et al. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 2010, 8:564-587.
62. Goulet C., Benchabane M., Anguenot R., Brunelle F., Khalf M., Michaud D. A companion protease inhibitor for the protection of cytosol-targeted recombinant proteins in plants. Plant Biotechnol J 2010, 82:142-154.
63. Gressel J., Valverde B.E. A strategy to provide long-term control of weedy rice while mitigating herbicide resistance transgene flow, and its potential use for other crops with related weeds. Pest Manag Sci 2009, 65:723-731.
64. Harvey A.J., Speksnijder G., Baugh L.R., Morris J.A., Ivarie R. Expression of exogenous protein in the egg white of transgenic chickens. Nat Biotechnol 2002, 20:396-399.
65. He Z., Jiang X.L., Qi Y., Di Q.L. Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression. Genetica 2008, 133:207-214.
66. Hiatt A., Cafferkey R., Bowdish K. Production of antibodies in transgenic plants. Nature 1989, 342:76-78.
67. Hills M.J., Hall L., Arnison P.G., Good A.G. Genetic use restriction technologies (GURTs): strategies to impede transgene movement. Trends Plant Sci 2007, 12:177-183.
68. Hohe A., Decker E., Gorr G., Schween G., Reski R. Tight control of growth and cell differentiation in photoautotrophically growing moss (Physcomitrella patens) bioreactor cultures. Plant Cell Rep 2002, 20:1135-1140.
69. Hood E.E., Witcher D.R., Maddock S., Meyer T., Baszczynski C., Bailey M., et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breed 1997, 3:291-306.
70. Horn M.E., Woodard S.L., Howard J.A. Plant molecular farming: systems and products. Plant Cell Rep 2004, 22:711-720.
71. Huang N., Bethell D., Card C., Cornish J., Marchbank T., Wyatt D., et al. Bioactive recombinant human lactoferrin, derived from rice. In Vitro Cell Dev Biol 2008, 44:464-471.
72. Hull A.K., Criscuolo C.J., Mett V., Groen H., Steeman W., Westra H., et al. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine 2005, 23:2082-2086.
73. Ismaili A., Jalali J.M., Rasaee M.J., Rahbarizadeh F., Forouzandeh-Moghadam M. Memari HR production and characterization of anti-(mucin MUC1) single-domain antibody in tobacco (Nicotiana tobacum cultivar Xanthi). Biotechnol Appl Biochem 2007, 47:11-19.
74. Jones D.N., Kroos R., Anema B., van Montfort B., Vooys A., van der Kraats S. High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 2003, 19:163-168.
75. Kaiser J. Is the drought over for pharming?. Science 2008, 320:473-475.
76. Kang J.S., Frank J., Kang C.H., Kajiura H., Vikram M., Ueda A. Salt tolerance of Arabidopsis thaliana requires maturation of N-glycosylated proteins in the Golgi apparatus. Proc Natl Acad Sci USA 2008, 105:5933-5938.
77. Kapila J., De Rycke R., van Montagu M., Angenon G. An agrobacterium-mediated transient gene expression system for intact leaves. Plant Sci 1997, 122:101-108.
78. Kawaguchi R., Bailey-Serres J. Regulation of translational initiation in plants. Curr Opin Plant Biol 2002, 5:460-465.
79. Key S., Ma J.K.C., Drake P.M.W. Genetically modified plants and human health. J R Soc Med 2008, 101:290-298.
80. Khalsa G., Mason H.S., Arntzen C.J. Plant-derived vaccines: progress and constrains. Molecular farming: plant-made pharmaceuticals and technical proteins 2004, 135-158. Wiley-VCH, Weinheim, Germany. R. Fischer, S. Schillberg (Eds.).
81. Kim T.G., Baek M., Lee E.K., Kwon T.-H., Yang M.-S. Expression of human growth hormone in transgenic rice cell suspension culture. Plant Cell Rep 2008, 27:885-891.
82. Knäblein J. Plant-based expression of biopharmaceuticals. Encyclopedia of molecular cell biology and molecular medicine 2005, 386-407. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. R.A. Meyers (Ed.).
83. Komarnytsky S., Borisjuk N., Yakoby N., Garvey A., Raskin I. Cosecretion of protease inhibitor stabilizes antibodies produced by plant roots. Plant Physiol 2006, 141:1185-1193.
84. Komarova T.V., Baschieri S., Donini M., Marusic C., Benvenuto E., Dorokhov Y.L. Transient expression systems for plant-derived biopharmaceuticals. Expert Rev Vaccin 2010, 9:859-876.
85. Koprivova A., Stemmer C., Altmann F., Hoffmann A., Kopriva S., Gorr G., et al. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2004, 2:517-523.
86. Koya V., Moayeri M., Leppla S.H., Daniell H. Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect Immun 2005, 73:8266-8274.
87. Krapp S., Mimura Y., Jefferis R., Huber R., Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 2003, 325:979-989.
88. Kumar S.G.B., Ganapathi T.R., Bapat V.A. Edible vaccines: current status and future prospects. Physiol Mov Biol Plants 2004, 10:37-47.
89. Kumar G.B.S., Ganapathi T.R., Revathi C.J., Srinivas L., Bapat V.A. Expression of hepatitis B surface antigen in transgenic banana plants. Planta 2005, 222:484-493.
90. Kusnadi A.R., Hood E.E., Witcher D.R., Howard J.A., Nikolov Z.L. Production and purification of two recombinant proteins from transgenic corn. Biotechnol Prog 1998, 14:149-155.
91. Lamphear B.J., Streatfield S.J., Jilka J.M., Brooks C.A., Barker D.K., Turner D.D., et al. Delivery of subunit vaccines in maize seed. J Control Release 2002, 85:169-180.
92. Lau O.S., Sun S.S.M. Plant seeds as bioreactors for recombinant protein production. Biotechnol Adv 2009, 27:1015-1022.
93. Lauterslager T.G.M., Florack D.E.A., Van der Wal T.J., Molthoff J.W., Langeveld J.P., Bosch D., et al. Oral immunization of naïve and primed animals with transgenic potato tubes expressing LT-B. Vaccine 2001, 19:2749-2755.
94. Leflon M., Hüsken A., Njontie C., Kightley S., Pendergrast D., Pierre J., et al. Stability of the cleistogamous trait during the flowering period of oilseed rape. Plant Breed 2009, 129:13-18.
95. Lentz E.M., Segretin M.E., Morgenfeld M.M., Wirth S.A., Santos M.J.D., Mozgovoj M.V., et al. High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants. Planta 2010, 231:387-395.
96. Leon-Banares R., Gonzalez-Ballester D., Galvan A., Fernandez E. Transgenic microalgae as green cell-factories. Trends Biotechnol 2004, 22:45-52.
97. Liénard D., Sourrouille C., Gomord V., Faye L. Pharming and transgenic plants. Biotechnol Ann Rev 2007, 13:115-147.
98. Ling H.-Y., Pelosi A., Walmsley A.M. Current status of plant-made vaccines for veterinary purposes. Expert Rev Vaccin 2010, 9:971-982.
99. Loos A., Van Droogenbroeck B., Hillmer S., Grass J., Kunert R., Cao J., et al. Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol J 2010, (early view, article online in advance of print). doi:10.1111/j.1467-7652.2010.00540.x.
100. Lowe J.A., Jones P. Biopharmaceuticals and the future of the pharmaceutical industry. Curr Opin Drug Discov Dev 2007, 10:513-514.
101. Lu J., Sivamani E., Azhakanandam K., Samadder P., Li X., Qu R. Gene expression enhancement mediated by the 5' UTR intron of the rice rubi3 gene varied remarkably among tissues in transgenic rice plants. Mol Genet Genomics 2008, 279:563-572.
102. Ma J.K.C., Lehner T., Stabila P., Fux C.I., Hiatt A. Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur J Immunol 1994, 24:131-138.
103. Ma J.K.C., Hikmat B.Y., Wycoff K., Vine N.D., Chargelegue D., Yu L., et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy. Nat Med 1998, 4:601-606.
104. Ma J.K.C., Barros E., Bock R., Christou P., Dale P.J., Dix P.J., et al. Molecular farming for new drugs and vaccine. EMBO Rep 2005, 6:593-599.
105. Maclean J., Koekemoer M., Olivier A.J., Stewart D., Hitzeroth I.I., Rademacher T., et al. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16L1 gene variants and different cell-compartment localization. J Gen Virol 2007, 88:1460-1469.
106. Maggio C., Barbante A., Ferro F., Frigerio L., Pedrazzini E. Intracellular sorting of the tailanchored protein cytochrome b5 in plants: a comparative study using different isoforms from rabbit and Arabidopsis. J Exp Bot 2007, 58:1365-1379.
107. Mainieri D., Rossi M., Archinti M., Bellucci M., De Marchis F., Vavassori S., et al. A new recombinant storage protein constructed using maize gamma-zein and bean phaseolin. Plant Physiol 2004, 136:3447-3456.
108. Marquet-Blouin E., Bouche F.B., Steinmetz A., Muller C.P. Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin. Plant Mol Biol 2003, 51:459-469.
109. Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K., Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 1996, 93:5335-5340.
110. Mason H.S., Warzecha H., Mor T., Arntzen C.J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 2002, 8:324-329.
111. Massa S., Franconi R., Brandi R., Muller A., Mett V., Yusibov V., et al. Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 2007, 25:3018-3021.
112. Mâsse B.R., Boily M.-C., Dimitrov D., Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol 2009, 6. 10.1186/1742-7622-6-5.
113. Masumura T., Morita S., Miki Y., Kurita A., Morita S., Shirono H., et al. Production of biologically active human interferon-α in transgenic rice. Plant Biotechnol 2006, 23:91-97.
114. Matsumoto K., Murata T., Nagao R., Nomura C.T., Arai S., Arai Y., et al. Production of shortchain-length/medium-chain-length polyhydroxyalkanoate (PHA) copolymer in the plastid of Arabidopsis thaliana using an engineered 3-ketoacyl-acyl carrier protein synthase III. Biomacromolecules 2009, 10:686-690.
115. Mayfield S.P., Franklin S.E. Expression of human antibodies in eukaryotic microalgae. Vaccine 2005, 23:1828-1832.
116. McCormick A.A., Reddy S., Reinl S.J., Cameron T.I., Czerwinkski D.K., Vojdani F., et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc Natl Acad Sci USA 2008, 105:10131-10136.
117. Mei C., Park S.H., Sabzikar R., Ransom C., Qi C., Sticklen M. Green tissue-specific production of a microbial endo-cellulase in maize (Zea mays L.) endoplasmic-reticulum and mitochondria converts cellulose to fermentable sugars. J Chem Technol Biotechnol 2009, 84:689-695.
118. Menassa R., Nguyen V., Jevnikar A., Brandle J.A. Self-contained system for the field production of plant recombinant interleukin-10. Mol Breed 2001, 8:177-185.
119. Mett V., Lyons J., Musiychuk, Chichester J.A., Brasil T., Couch R., et al. A plant-produced plague vaccine candidate confers protection to monkeys. Vaccine 2007, 25:3014-3017.
120. Meyers B., Zaltsman A., Lacroix B., Kozlovsky S.V., Krichevsky A. Nuclear and plastid genetic engineering of plants: comparison of opportunities and challenges. Biotechnol Adv 2010, 10.1016/j.biotechadv.2010.05.022.
121. Milne R. Public attitudes toward molecular farming in the UK. AgBioForum 2008, 11:106-113.
122. Mishra S., Yadav D.K., Tuli R. Ubiquitin fusion enhances cholera toxin B subunit expression in transgenic plants and the plant-expressed protein binds GM1 receptors more efficiently. J Biotechnol 2006, 127:95-108.
123. Moloney M.M., Siloto R.M. Modified oleosins. US 10/561 2004, 178.
124. Moravec T., Schmidt M.A., Herman E.M., Woodford-Thomas T. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 2007, 25:1647-1657.
125. Musa T.A., Hung C.Y., Darlington D.E., Sane D.C., Xie J. Overexpression of human erythropoietin in tobacco does not affect plant fertility or morphology. Plant Biotechnol Rep 2009, 3:157-165.
126. Nagaya S., Kawamura K., Shinmyo A., Kato K. The HSP terminator of Arabidopsis thaliana increases gene expression in plant cells. Plant Cell Physiol 2010, 51:328-332.
127. Nara Y., Kurata H., Seki M., Taira K. Glucocorticoid-induced expression of a foreign gene by the GVG system in transformed tobacco BY-2 cells. Biochem Eng J 2000, 6:185-191.
128. Nicholson L., Gonzalez-Melendi P., van Dolleweerd C., Tuck H., Perrin Y., Ma J.K., et al. A recombinant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. Plant Biotechnol J 2005, 3:115-127.
129. Nielsen K.M., Bones A., Smalla K., van Elsas J.D. Horizontal gene transfer from transgenic plants to terrestrial bacteria-a rare event?. FEMS Microbiol Rev 1998, 22:79-103.
130. Nochi T., Takagi H., Yuki Y., Yang L., Masumura T., Mejima M., et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci USA 2007, 104:10986-10991.
131. Nykiforuk C.L., Boothe J.G., Murray E.W., Keon R.G., Goren H.J., Markley N.A., et al. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 2006, 4:77-85.
132. Nykiforuk C.L., Shen Y., Murray E.W., Boothe J.G., Busseuil D., Rhéaume E., et al. Expression and recovery of biologically active recombinant apolipoprotein AI (Milano) from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnol J 2010, (Early view, article online in advance of print). doi:10.1111/j.1467-7652.2010.00546.x.
133. Obembe O.O. The plant biotechnology flight: is Africa on board?. Afri J Biotechnol 2010, 9:4300-4308.
134. Obembe O.O., Jacobsen E., Visser R.G.F., Vincken J.-P. Expression of an expansin carbohydrate-binding module affects xylem and phloem formation. Afri J Biotechnol 2007, 6:1608-1616.
135. Obembe O.O., Jacobsen E., Timmers J., Gilbert H., Blake A.W., Knox J.P., et al. Promiscuous, non-catalytic, tandem carbohydrate-binding modules modulate the cell-wall structure and development of transgenic tobacco (Nicotiana tabacum) plants. J Plant Res 2007, 120:605-617.
136. Oey M., Lohse M., Kreikemeyer B., Bock R. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J 2009, 57:436-445.
137. O'Keefe B.R., Vojdani F., Buffa V., Shattock R.J., Montefiori D.C., Bakke J., et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci USA 2009, 106:6099-6104.
138. Paul M., Ma J.K. Plant-made immunogens and effective delivery strategies. Expert Rev Vaccin 2010, 9:821-833.
139. Peebles C.A.M., Gibson S.I., Shanks J.V., San K.Y. Characterization of an ethanol-inducible promoter system in Catharanthus roseus hairy roots. Biotechnol Prog 2007, 23:1258-1260.
140. Philip R., Darnowski D.W., Maughan P.J., Vodkin L.O. Processing and localization of bovine b-casein expressed in transgenic soybean seeds under control of a soybean lectin expression cassette. Plant Sci 2001, 161:323-335.
141. Plasson C., Michel R., Lienard D., Saint-Jore-Dupas C., Sourrouille C., de March G.G., et al. Production of recombinant proteins in suspension-cultured plant cells. Meth Mol Biol 2009, 483:145-161.
142. Pogue G.P., Vojdani F., Palmer K.E., Hiatt E., Hume S., Phelps J., et al. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol J 2010, 8:638-654.
143. Porta C., Lomonossoff G.P. Viruses as vectors for the expression of foreign sequences in plants. Biotechnol Genet Eng Rev 2002, 19:245-291.
144. Pujol M., Ramírez N.I., Ayala M., Gavilondo J.V., Valdés R., Rodríguez M., et al. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine 2005, 23:1833-1837.
145. Rademacher T., Sack M., Arcalis E., Stadlmann J., Balzer S., Altmann F., et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J 2008, 6:189-201.
146. Ramessar K., Sabalza M., Capell T., Christou P. Maize plants: an ideal production platform for effective and safe molecular pharming. Plant Sci 2008, 174:409-419.
147. Ramessar K., Rademacher T., Sack M., Stadlmann J., Platis D., Stiegler G., et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 2008, 105:3727-3732.
148. Reddy V.S., Sadhu L., Selvapandiyan A., Raman R., Giovanni F., Shukla V., et al. Analysis of chloroplast transformed tobacco plants with cry1Ia5 under rice psbA transcriptional elements reveal high level expression of Bt toxin without imposing yield penalty and stable inheritance of transplastome. Mol Breed 2002, 9:259-269.
149. Regnard G.L., Halley-Stott R.P., Tanzer F.L., Hitzeroth I.I., Rybicki E.P. High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J 2010, 8:38-46.
150. Richter L.J., Thanavala Y., Arntzen C.J., Mason H.S. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 2000, 18:1167-1171.
151. Rosales-Mendoza S., Alpuche-Solis A.G., Soria-Guerra R.E., Moreno-Fierros L., Martínez-González L., Herrera-Díaz A., et al. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. Plant J 2009, 57:45-54.
152. Rosales-Mendoza S., Soria-Guerra R.E., Moreno-Fierros L., Alpuche-Solís Á.G., Martínez-González L., Korban S.S. Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague. Planta 2010, 10.1007/s00425-010-1176-z.
153. Rotino G.L., Acciarri N., Sabatini E., Mennella G., Lo Scalzo R., Maestrelli A., et al. Open field trial of genetically modified parthenocarpic tomato: seedlessness and fruit quality. BMC Biotechnol 2005, 5.
154. Russell D.A., Spatola L.A., Dian T., Paradkar V.M., Dufield D.R., Carroll J.A., et al. Host limits to accurate human growth hormone production in multiple plant systems. Biotechnol Bioeng 2005, 89:775-782.
155. Rybicki E.P. Plant-produced vaccines: promise and reality. Drug Discov Today 2009, 14:16-24.
156. Rybicki E.P. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010, 8:620-637.
157. Sadhu L., Reddy V.S. Chloroplast expression of His-tagged GUS-fusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors. Mol Breed 2003, 11:49-58.
158. Sandhu S., James V.A., Quesenberry K.H., Altpeter F. Risk assessment of transgenic apomictic tetraploid bahiagrass, cytogenetics, breeding behavior and performance of intra-specific hybrids. Theor Appl Genet 2009, 119:1-13.
159. Santi L., Giritch A., Roy C.J., Marillonnet S., Klimyuk V., Gleba Y., et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 2006, 103:861-866.
160. Satyavathi V.V., Prasad V., Khandelwal A., Shaila M.S., Sita G.L. Expression of hemagglutinin protein of rinderpest virus in transgenic pigeon pea [Cajanus cajan (L.) Millsp.] plants. Plant Cell Rep 2003, 21:651-658.
161. Schaefer D.G. A new moss genetics: targeted mutagenesis in Physcomitrella patens. Annu Rev Plant Biol 2002, 53:477-501.
162. Schillberg S., Zimmermann S., Voss A., Fischer R. Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic Res 1999, 8:255-263.
163. Schillberg S., Twyman R.M., Fischer R. Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine 2005, 23:1764-1769.
164. Shaaltiel Y., Bartfeld D., Hashmueli S., Baum G., Brill-Almon E., Galili G., et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol J 2007, 5:579-590.
165. Sharma A.K., Sharma M.K. Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv 2009, 27:811-832.
166. Sharma M.K., Singh N.K., Jani D., Sisodia R., Thungapathra M., Gautam J.K., et al. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to choleratoxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Rep 2008, 27:307-318.
167. Sijmons P.C., Dekker B.M., Schrammeijer B., Verwoerd T.C., van den Elzen P.J.M., Hoekema A.A. Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY) 1990, 8:217-221.
168. Singh A.K., Verma S.S. Plastid transformation in eggplant (Solanum melongena L.). Transgenic Res 2010, 19:113-119.
169. Sojikul P., Buehner N., Mason H.S. A plant signal peptide hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc Natl Acad Sci USA 2003, 100:2209-2214.
170. Sourrouille C., Marquet-Blouin E., D'Aoust M.A., Kiefer-Meyer M.-C., Seveno M., Pagny-Salehabadi S., et al. Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J 2008, 6:702-721.
171. Sparrow P.A., Irwin J.A., Dale P.J., Twyman R.M., Ma J.K. Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res 2007, 16:147-161.
172. Spök A. Molecular farming on the rise-GMO regulators still walking a tightrope. Trends Biotechnol 2007, 25:74-82.
173. Spök A., Twyman R.M., Fischer R., Ma J.K., Sparrow P.A. Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol 2008, 26:506-517.
174. Stefanova G., Vlahova M., Atanassov A. Production of recombinant human lactoferrin from transgenic plants. Biol Plant 2008, 52:423-428.
175. Sticklen M.B. Plant genetic engineering for biofuel production: towards affordable cellulosic ethanol. Nat Rev Gen 2008, 9:433-443.
176. Stoger E., Sack M., Fischer R., Christou P. Plantibodies: applications, advantages and bottlenecks. Curr Opin Biotechnol 2002, 13:161-166.
177. Stoger E., Ma J.K.C., Fischer R., Christou P. Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 2005, 16:167-173.
178. Stoger E., Sack M., Nicholson L., Fischer R., Christou P. Recent progress in plantibody technology. Curr Pharm Des 2005, 11:2439-2457.
179. Streatfield S.J., Howard J.A. Plant-based vaccines. Int J Parasitol 2003, 33:479-493.
180. Streatfield S.J. Mucosal immunization using recombinant plant-based oral vaccines. Methods 2006, 38:150-157.
181. Streatfield S.J. Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 2007, 5:2-15.
182. Sugio T., Matsuura H., Matsui T., Matsunaga M., Nosho T., Kanaya S., et al. Effect of the sequence context of the AUG initiation codon on the rate of translation in dicotyledonous and monocotyledonous plant cells. J Biosci Bioeng 2010, 109:170-173.
183. Svab Z., Maliga P. Exceptional transmission of plastids and mitochondria from the transplastomic pollen parent and its impact on transgene containment. Proc Natl Acad Sci USA 2007, 104:7003-7008.
184. Tacket C.O. Plant-derived vaccines against diarrheal diseases. Vaccine 2005, 23:1866-1869.
185. Takagi H., Hiroi T., Yang L., Tada Y., Yuki Y., Takamura K., et al. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci USA 2005, 102:17525-17530.
186. Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2003, 60:523-533.
187. Thanavala Y., Mahoney M., Pal S., Scott A., Richter L., Natarajan N., et al. Immunogenicity in humans of an ediblevaccine for hepatitis B. Proc Natl Acad Sci USA 2005, 102:3378-3382.
188. Tiwari S., Verma P.C., Singh P.K., Tuli R. Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 2009, 27:449-467.
189. Torrent M., Llompart B., Lasserre-Ramassamy S., Llop-Tous I., Bastida M., Marzabal P., et al. Eukaryotic protein production in designed storage organelles. BMC Biol 2009, 7:5.
190. Torrent M., Llop-Tous I., Ludevid M.D. Protein body induction: a new tool to produce and recover recombinant proteins in plants. Meth Mol Biol 2009, 483:193-208.
191. Tran M., Zhou B., Pettersson P.L., Gonzalez M.J., Mayfield S.P. Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol Bioeng 2009, 104:663-673.
192. Tregoning J.S., Clare S., Bowe F., Edwards L., Fairweather N., Qazi O., et al. Protection against tetanus toxin using a plant-based vaccine. Eur J Immunol 2005, 35:1320-1326.
193. Tremblay R., Wang D., Jevnikar A.M., Ma S. Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol Adv 2010, 28:214-221.
194. US Department of Agriculture BRS factsheet. USDA-APHIS 2006, Available from:, accessed 20/8/09. http://www.aphis.usda.gov/publications/biotechnology/content/printable_version/BRS_FS_pharmaceutical_02-06.pdf.
195. USDA/APHIS Draft guidance for APHIS permits for field testing or movement of organisms with pharmaceutical or industrial intent 2006, accessed 20/8/09. http://www.aphis.usda.gov/brs/pdf/Pharma_Guidance.pdf.
196. Varsani A., Williamson A.L., Rose R.C., Jaffer M., Rybicki E.P. Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch Virol 2003, 148:1771-1786.
197. Varsani A., Williamson A.-L., Stewart D., Rybicki E.P. Transient expression of human papillomavirus type 16L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Res 2006, 120:91-96.
198. Vézina L.-P., Faye L., Lerouge P., D'Aoust M.-A., Marquet-Blouin E., Burel C., et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J 2009, 7:442-455.
199. Villani M.E., Morgun B., Brunetti P., Marusic C., Lombardi R., Pisoni I., et al. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnol J 2008, 6:59-72.
200. Voinnet O., Rivas S., Mestre P., Baulcombe D. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J 2003, 33:949-956.
201. Walmsley A.M., Arntzen C.J. Plant cell factories and mucosal vaccines. Curr Opin Biotechnol 2003, 14:145-150.
202. Weise A., Altmann F., Rodríguez-Franco M., Sjoberg E.R., Bäumer W., Launhardt H., et al. High-level expression of secreted complex glycosylate recombinant human erythropoietin in the Physcomitrella D-fuc-t D-xyl-t mutant. Plant Biotechnol J 2007, 5:389-401.
203. Wilde C.D., Peeters K., Jacobs A., Peck I., Depicker A. Expression of antibodies and Fab fragments in transgenic potato plants: a case study for bulk production in crop plants. Mol Breed 2002, 9:271-282.
204. Wirth S., Calamante G., Mentaberry A., Bussmann L., Lattanzi M., Barañao L., et al. Expression of active human epidermal growth factor (hEGF) in tobacco plants by integrative and non-integrative systems. Mol Breed 2004, 13:23-35.
205. Wisner R. The economics of pharmaceutical crops: potential benefits and risks for farmers and rural communities, Union of Concerned Scientists 2005, Sep. Available from:, accessed 20/8/09. http://www.ucsusa.org/food_and_environment/genetic_engineering/economics-of-pharmaceutical-crops.html.
206. Woodard S.L., Mayor J.M., Bailey M.R., Barker D.K., Love R.T., Lane J.R., et al. Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol Appl Biochem 2003, 38:123-130.
207. Xu B., Copolla M., Herr J.C., Timko M.P. Expression of a recombinant human sperm-agglutinating mini-antibody in tobacco (Nicotiana tabacum L). Soc Reprod Fertil Suppl 2007, 63:465-477.
208. Yamada Y., Nishizawa K., Yokoo M., Zhao H., Onishi K., Teraishi M., et al. Anti-hypertensive activity of genetically modified soybean seeds accumulating novokinin. Peptides 2008, 29:331-337.
209. Yang D., Wu L., Hwang Y.S., Chen L., Huang N. Expression of the REB transcriptional activator in rice grains improves the yield of recombinant proteins whose genes are controlled by a Reb-responsive promoter. Proc Natl Acad Sci USA 2001, 98:11438-11443.
210. Yang D., Guo F., Liu B., Huang N., Watkins S.C. Expression and localization of human lysozyme in the endosperm of transgenic rice. Planta 2003, 216:597-603.
211. Yano M., Hirai T., Kato K., Hiwasa-Tanase K., Fukuda N., Ezura H. Tomato is a suitable material for producing recombinant miraculin protein in genetically stable manner. Plant Sci 2010, 178:469-473.
212. Zeitlin L., Pauly M., Whaley K.J. Second-generation HIV microbicides: continued development of griffithsin. Proc Natl Acad Sci USA 2009, 106:6029-6030.
213. Zhu Z., Hughes K.W., Huang L., Sun B., Liu C., Li Y. Expression of human alpha-interferon cDNA in transgenic rice plants. Plant Cell Tissue Organ Cult 2004, 36:197-204.